Now showing items 1-4 of 4

    • Autotrasplante (AT) de progenitores hematopoyéticos en mieloma múltiple. Experiencia clínica 

      Flores, Claudio; Conte Lanza, Guillermo; Fardella, Patricia; Araos, Daniel; Alfaro Lucero, Jorge; Aravena Rodríguez, Paola Carolina; González Gómez, Néstor; Larrondo Lillo, Milton (SOC MEDICA SANTIAGO, 2005-08)
      Background: Multiple myeloma is rarely curable. Advances in high dose chemotherapy and stem cell transplantation have improved overall survival and event-free disease periods, but relapses are inevitable. Aim: To report ...
    • Dendritic cell chimerism in oral mucosa of transplanted patients affected by graft-versus-host disease 

      Pérez, Claudio A.; Rabanales, Ramón; Rojas Alcayaga, Gonzalo; Larrondo Lillo, Milton; Escobar Álvarez, Alejandro; López, Mercedes N.; Salazar Onfray, Flavio; Alfaro Lucero, Jorge; González, Fermin E. (John Wiley & Sons, 2016)
      ObjectiveGraft-versus-host disease (GVHD) is one of the main complications after haematopoietic stem cell transplantation. Clinical features of GVHD include either an acute (aGVHD) or a chronic (cGVHD) condition that affects ...
    • Linfoma intravascular tratado con anticuerpos monoclonales anti CD20: descripción de un caso clínico 

      Alfaro Lucero, Jorge; Espinoza N., Arturo; Manríquez A., María; Moyano Schlegel, Leonor; González Gómez, Néstor; Larrondo Lillo, Milton; Figueroa Maureira, Gastón (SOC MEDICA SANTIAGO, 2004-11)
      We report a 78 year old male with prostatism, that was subjected to a prostate biopsy. The pathological study showed a microvascular lymphocytic infiltration. Four months later, the patients presented with reduced alertness, ...
    • Respuesta inmune contra antígenos menores de histocompatibilidad en el trasplante alogénico de progenitores hematopoyéticos 

      Rabanales T., Ramón; Larrondo Lillo, Milton; Alfaro Lucero, Jorge; Pérez Núñez, Claudio (Hospital Clínico Universidad de Chile, 2010)
      Patients who receive allo hematopoietic stem cell transplantation (SCT) could develop graft versus host disease and/or graft versus tumour effect. These immunological responses can happen even with perfect fully HLA matched ...